December 6, 2023 BHR Newsletter 1. 3 patients die in cancer drug trial Full story 2. Cancer society urges lawmakers to resolve drug shortages Full story 3. The fellowship specialties with the most placements Full story 4. Precision medicine can…
Oncology Report
December 4, 2023 BHR Newsletter 1. Fred Hutch takes IT systems offline following cyberattack Full story 2. Emory University taps surgical oncologist to lead its medical school Full story 3. How HCA is moving the needle in lung cancer care…
November 29, 2023 BHR Newsletter 1. FDA investigates potential link between CAR-T therapy and lymphoma Full story 2. NYU Langone replaces cancer center director after predecessor's firing Full story 3. Northwell opens $32M cancer center Full story 4. In the…
November 27, 2023 BHR Newsletter 1. FDA finalizes guidelines on real-time oncology review Full story 2. South Carolina system taps cancer surgeon as interim CEO Full story 3. States with the highest, lowest lung cancer survival rates Full story 4. True…
November 20, 2023 BHR Newsletter 1. Youth cancer mortality falls 24% Full story 2. FDA eyes efficacy of $900K cancer drug Full story 3. Vanderbilt physician to head National Cancer Institute Full story 4. Some infusion centers are making an…
November 15, 2023 BHR Newsletter 1. States with the fewest oncologist per capita Full story 2. Franciscan Health receives $30M donation for cancer center Full story 3. NYU Langone streamlines spine radiosurgery treatment to 1 day Full story 4. A…
November 13, 2023 BHR Newsletter 1. MD Anderson to create 1st-of-its-kind oncology nursing institute Full story 2. RWJBarnabas Health, Rutgers Cancer Institute partner on care programs Full story 3. Dana-Farber gets $72M donation Full story 4. UCLA Health Jonsson Comprehensive…
November 8, 2023 BHR Newsletter 1. Mass General Brigham creates new role ahead of Dana-Farber split Full story 2. 10 states with most oncologists per capita Full story 3. City of Hope taps new chief clinical officer Full story 4. Some infusion…
November 6, 2023 BHR Newsletter 1. FDA puts clinical hold on cancer drug study Full story 2. Genetic mutation diminishes drug response in some cancer patients Full story 3. 2 NYU Langone physicians suspended over social media posts on Israel,…
November 1, 2023 BHR Newsletter 1. FDA approves new head and neck cancer drug Full story 2. 3 ways cancer care needs to change, per 8 leaders Full story 3. Lung cancer guidelines updated for 1st time in a…